Transaction in Own Shares

Summary by AI BETAClose X

Hikma Pharmaceuticals PLC reports that between August 10th and August 14th, 2026, it repurchased a total of 575,351 ordinary shares as part of its $250 million share repurchase program. The company intends to cancel these shares, and following these transactions, the total number of issued ordinary shares will be 209,008,632, with the total voting rights remaining the same.

Disclaimer*

UK 100

Latest directors dealings